These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. SARS-CoV-2 specific antibody responses after third CoronaVac or BNT162b2 vaccine following two-dose CoronaVac vaccine regimen. Keskin AU; Bolukcu S; Ciragil P; Topkaya AE J Med Virol; 2022 Jan; 94(1):39-41. PubMed ID: 34536028 [No Abstract] [Full Text] [Related]
4. Should a third booster dose be scheduled after two doses of CoronaVac? A single-center experience. Yigit M; Ozkaya-Parlakay A; Cosgun Y; Ince YE; Bulut YE; Senel E J Med Virol; 2022 Jan; 94(1):287-290. PubMed ID: 34487373 [TBL] [Abstract][Full Text] [Related]
5. Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine. Melo-González F; Soto JA; González LA; Fernández J; Duarte LF; Schultz BM; Gálvez NMS; Pacheco GA; Ríos M; Vázquez Y; Rivera-Pérez D; Moreno-Tapia D; Iturriaga C; Vallejos OP; Berríos-Rojas RV; Hoppe-Elsholz G; Urzúa M; Bruneau N; Fasce RA; Mora J; Grifoni A; Sette A; Weiskopf D; Zeng G; Meng W; González-Aramundiz JV; González PA; Abarca K; Ramírez E; Kalergis AM; Bueno SM Front Immunol; 2021; 12():747830. PubMed ID: 34858404 [TBL] [Abstract][Full Text] [Related]
6. Neutralization of alpha, gamma, and D614G SARS-CoV-2 variants by CoronaVac vaccine-induced antibodies. Fernández J; Bruneau N; Fasce R; Martín HS; Balanda M; Bustos P; Ulloa S; Mora J; Ramírez E J Med Virol; 2022 Jan; 94(1):399-403. PubMed ID: 34460119 [TBL] [Abstract][Full Text] [Related]
10. The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines. Chan RWY; Liu S; Cheung JY; Tsun JGS; Chan KC; Chan KYY; Fung GPG; Li AM; Lam HS Front Immunol; 2021; 12():744887. PubMed ID: 34712232 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity, safety and reactogenicity of a heterogeneous booster following the CoronaVac inactivated SARS-CoV-2 vaccine in patients with SLE: a case series. Assawasaksakul T; Sathitratanacheewin S; Vichaiwattana P; Wanlapakorn N; Poovorawan Y; Kittanamongkolchai W RMD Open; 2021 Dec; 7(3):. PubMed ID: 34862313 [TBL] [Abstract][Full Text] [Related]
12. An investigation of the seroprevalence of CrimeanCongo Hemorrhagic Fever and Lumpy Skin Disease in domesticated water buffaloes in northern Turkey. Okur-Gumusova S; Tamer C; Ozan E; Cavunt A; Kadi H; Muftuoglu B; Eisa Elhag A; Yazici Z; Albayrak H Trop Biomed; 2020 Mar; 37(1):165-173. PubMed ID: 33612727 [TBL] [Abstract][Full Text] [Related]
13. West nile virus infection in the Mesopotamia region, Syria border of Turkey. Karakoç ZÇ; Tüzüner BM; Ergonul O; Pierro A; Di Fonzo E; Koruk İ; Sambri V Vector Borne Zoonotic Dis; 2013 Oct; 13(10):739-43. PubMed ID: 23808974 [TBL] [Abstract][Full Text] [Related]
14. Immunogenicity after two doses of inactivated virus vaccine in healthcare workers with and without previous COVID-19 infection: Prospective observational study. Yalçın TY; Topçu DI; Doğan Ö; Aydın S; Sarı N; Erol Ç; Kuloğlu ZE; Azap ÖK; Can F; Arslan H J Med Virol; 2022 Jan; 94(1):279-286. PubMed ID: 34468990 [TBL] [Abstract][Full Text] [Related]